当前位置:首页 - 行情中心 - 京新药业(002020) - 财务分析 - 现金流量表

京新药业

(002020)

  

流通市值:139.07亿  总市值:165.40亿
流通股本:7.24亿   总股本:8.61亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,855,922,463.22904,830,649.223,780,975,678.352,838,651,137.39
  收到的税费返还26,643,984.9415,528,144.2366,978,964.0757,322,939.51
  收到其他与经营活动有关的现金67,221,938.1738,222,334.38170,398,213.48168,847,038.65
  经营活动现金流入小计1,949,788,386.33958,581,127.834,018,352,855.93,064,821,115.55
  购买商品、接受劳务支付的现金691,112,290.9385,898,939.11,616,059,983.681,100,794,598.42
  支付给职工以及为职工支付的现金335,413,164.49165,842,653.6601,822,678.47459,664,700.7
  支付的各项税费220,624,139.6194,725,100.23327,859,882.36285,627,033.66
  支付其他与经营活动有关的现金309,730,367.08149,221,691.2746,448,940.58606,041,569.84
  经营活动现金流出小计1,556,879,962.08795,688,384.133,292,191,485.092,452,127,902.62
  经营活动产生的现金流量净额392,908,424.25162,892,743.7726,161,370.81612,693,212.93
二、投资活动产生的现金流量:
  收回投资收到的现金1,574,000,0001,087,000,0004,098,588,0003,263,627,519.33
  取得投资收益收到的现金20,377,995.3610,543,777.0162,389,005.99,941,772.48
  处置固定资产、无形资产和其他长期资产收回的现金净额133,980.658,080.65,201,315.851,402,300.5
  收到的其他与投资活动有关的现金--2,038,4002,400,100
  投资活动现金流入小计1,594,511,975.961,097,601,857.614,168,216,721.753,277,371,692.31
  购建固定资产、无形资产和其他长期资产支付的现金122,922,973.01103,128,113.97250,645,590.66181,753,715.24
  投资支付的现金839,000,000524,000,0005,338,863,145.214,623,863,145.21
  支付其他与投资活动有关的现金--16,570,000-
  投资活动现金流出小计961,922,973.01627,128,113.975,606,078,735.874,805,616,860.45
  投资活动产生的现金流量净额632,589,002.95470,473,743.64-1,437,862,014.12-1,528,245,168.14
三、筹资活动产生的现金流量:
  吸收投资收到的现金--400,000400,000
  其中:子公司吸收少数股东投资收到的现金--400,000400,000
  取得借款收到的现金283,131,386.1489,356,633.35738,289,997.22569,154,941.68
  收到其他与筹资活动有关的现金368,162.81-172,374.96-
  筹资活动现金流入小计283,499,548.9589,356,633.35738,862,372.18569,554,941.68
  偿还债务支付的现金282,000,000182,000,000742,000,000452,000,000
  分配股利、利润或偿付利息支付的现金288,540,870.41-261,462,561.24261,462,561.24
  其中:子公司支付给少数股东的股利、利润3,687,124.66-3,153,819.243,153,819.24
  支付其他与筹资活动有关的现金621,318,118.66446,311,014.6915,562,726.0111,971,980.61
  筹资活动现金流出小计1,191,858,989.07628,311,014.691,019,025,287.25725,434,541.85
  筹资活动产生的现金流量净额-908,359,440.12-538,954,381.34-280,162,915.07-155,879,600.17
四、汇率变动对现金及现金等价物的影响202,617.314,003.552,990,123.33-400,802.79
五、现金及现金等价物净增加额117,340,604.3994,416,109.55-988,873,435.05-1,071,832,358.17
  加:期初现金及现金等价物余额287,144,932.7287,144,932.71,276,018,367.751,276,018,367.75
  期末现金及现金等价物余额404,485,537.09381,561,042.25287,144,932.7204,186,009.58
补充资料:
  净利润392,203,288.29-719,126,111.66-
  资产减值准备6,014,437.25-27,382,256.77-
  固定资产和投资性房地产折旧148,129,426.4-259,876,131.2-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧148,129,426.4-259,876,131.2-
  无形资产摊销9,077,769.18-21,671,483.69-
  长期待摊费用摊销8,031,506.84-15,488,551.56-
  处置固定资产、无形资产和其他长期资产的损失256,693.52--2,587,796.61-
  固定资产报废损失39,516.37-72,956.09-
  公允价值变动损失-67,808.22-42,367,026.33-
  财务费用164,818.72-4,817,593.46-
  投资损失-12,490,027.76--8,957,002.94-
  递延所得税-7,025,358.05--16,644,703.48-
  其中:递延所得税资产减少-10,690,217.42--2,577,712.04-
    递延所得税负债增加3,664,859.37--14,066,991.44-
  存货的减少-40,660,090.63--152,839,858.99-
  经营性应收项目的减少-11,156,408.46--249,645,918.61-
  经营性应付项目的增加-106,638,983.81-52,301,028.08-
  融资租入固定资产--7,715,951.1-
  现金的期末余额404,485,537.09-287,144,932.7-
  减:现金的期初余额287,144,932.7-1,276,018,367.75-
  现金及现金等价物的净增加额117,340,604.39--988,873,435.05-
公告日期2025-08-272025-04-282025-04-032024-10-25
审计意见(境内)标准无保留意见
TOP↑